Pharyngocise Dose Response Study
Dysphagia
About this trial
This is an interventional prevention trial for Dysphagia focused on measuring swallowing disorders, swallowing therapy, head neck cancer, oropharyngeal dysphagia
Eligibility Criteria
Inclusion Criteria:
- Head/Neck cancer of the oropharyngeal or adjacent regions, confirmed by clinical history and exam, with positive cross sectional imaging studies and histopathological biopsy excluding other pathology.
- Planned external beam radiation therapy
- No previous history of non-oral feeding for cancer related illness
- Able to undergo MRI imaging scan
- Patient and physician agreement to enter the study
Exclusion Criteria:
- Planned extensive surgical intervention
- Existence of a co-existing neurological or medical disorder known to cause dysphagia
- Prior radiotherapy or surgery to the head / neck region that could contribute to dysphagia.
- Previous swallowing therapy within four weeks of randomization
- Gross tumor involvement of the oral and pharyngeal muscles obviating adequate MRI measurements of the majority of muscles of interest.
Sites / Locations
- Shands Cancer Center, University of Florida
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Active Comparator
Usual care
High Intensity Pharyngocise
Low Intensity Pharyngocise
Control (Usual care) group in which patients will receive swallowing and prescribed dietary intervention during the radiotherapy period prescribed by the attending physician.
Patients receive twice daily swallowing intervention by a speech language pathologist, consisting of the battery of isometric / isotonic exercises.
Patients will receive a one time only swallowing intervention session by a speech language pathologist, instructing them in the battery of isometric / isotonic exercises plus a home practice instruction digital video tape to support self directed practice of this program at home.